![Fouad Namouni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fouad Namouni
Director/Board Member at
VOR BIOPHARMA INC.
Net worth: - $ as of 2026-05-30
Profile
Dr. Fouad Namouni, MD, is a President-Research & Development at Blueprint Medicines Corp. and an Independent Director at Aprea Therapeutics, Inc. He is on the Board of Directors at Aprea Therapeutics, Inc. Dr. Namouni was previously employed as a Head-Oncology Development by Bristol Myers Squibb Co.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VOR BIOPHARMA, INC. -.--% | 2026-06-10 | 0 ( -.--% ) | - $ | 2026-05-30 |
Fouad Namouni active positions
| Companies | Position | Start |
|---|---|---|
| VOR BIOPHARMA INC. | Director/Board Member | 2024-04-29 |
Former positions of Fouad Namouni
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 2025-09-30 |
| APREA THERAPEUTICS, INC. | Director/Board Member | 2022-05-15 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Training of Fouad Namouni
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Université de Paris XI Paris Sud
 Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
- Stock Market
- Insiders
- Fouad Namouni
